Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Int. braz. j. urol ; 48(1): 122-130, Jan.-Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1356274

ABSTRACT

ABSTRACT Purpose: To analyze the association between obesity and urinary incontinence rate in men submitted to robot-assisted radical prostatectomy (RARP) in a high-volume cancer center. Materials and Methods: We reported 1.077 men who underwent RARP as the primary treatment for localized prostate cancer from 2013 to 2017. Patients were classified as non-obese (normal BMI or overweight) or obese men (BMI ≥30kg/m2). They were grouped according to the age, PSA level, D'Amico risk group, Gleason score, ASA classification, pathological stage, prostate volume, salvage/adjuvant radiotherapy, perioperative complications, and follow-up time. Urinary continence was defined as the use of no pads. For the analysis of long-term urinary continence recovery, we conducted a 1:1 propensity-score matching to control confounders. Results: Among the obese patients, mean BMI was 32.8kg/m2, ranging 30 - 45.7kg/m2. Only 2% was morbidly obese. Obese presented more comorbidities and larger prostates. Median follow-up time was 15 months for the obese. Complications classified as Clavien ≥3 were reported in 5.6% of the obese and in 4.4% of the non-obese men (p=0.423). Median time for continence recovery was 4 months in both groups. In this analysis, HR was 0.989 for urinary continence recovery in obese (95%CI=0.789 - 1.240; p=0.927). Conclusions: Obese can safely undergo RARP with similar continence outcomes comparing to the non-obese men when performed by surgeons with a standardized operative technique. Future studies should perform a subgroup analysis regarding the association of obesity with other comorbidities, intending to optimize patient counseling.


Subject(s)
Humans , Male , Prostatic Neoplasms/surgery , Prostatic Neoplasms/complications , Obesity, Morbid , Robotic Surgical Procedures/adverse effects , Prostate/surgery , Prostatectomy/adverse effects , Treatment Outcome , Recovery of Function , Propensity Score
2.
Int. braz. j. urol ; 47(3): 558-565, May-June 2021. tab, graf
Article in English | LILACS | ID: biblio-1154500

ABSTRACT

ABSTRACT Purpose: Incidence and mortality of prostate cancer (PCa) are still increasing in developing countries. Limited access to the health system or more aggressive disease are potential reasons for this. Ethnic and social differences in developed countries seem to make inappropriate to extrapolate data from other centers. We aim to report the epidemiological profile of a PSA-screened population from a cancer center in Brazil. Materials and Methods: We retrospectively selected 9.692 men enrolled in a PCa prevention program, comprising total PSA level and digital rectal examination at the first appointment, associated with complementary tests when necessary. Men aged over 40 years-old were included after shared decision-making process. Prostate biopsy (TRUS) was performed when clinically suspected for PCa. After the diagnosis, patients underwent appropriate treatment. Results: TRUS was performed in 5.5% of men and PCa incidence was 2.6%. Overall ratio between number of patients who needed to be screened in order to diagnose one cancer was 38.9 patients, with 2.1 biopsies performed to diagnose a cancer. Positive predictive value (PPV) of TRUS biopsy in this strategy was 47.2%, varying from 38.5% (<50 years-old) to 60% (>80 years-old). We evidenced 70 patients (27.9%) classified as low risk tumors, 74 (29.5%) as intermediate risk, and 107 (42.6%) as high-risk disease. Conclusions: PSA-screening remains controversial in literature. In front of a huge miscegenated people and considering the big proportion of high-risk PCa, even in young men diagnosed with the disease, it is imperative to inform patients and health providers about these data particularities in Brazil.


Subject(s)
Humans , Male , Adult , Aged , Aged, 80 and over , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/epidemiology , Prostate-Specific Antigen/analysis , Biopsy , Brazil/epidemiology , Public Health , Predictive Value of Tests , Retrospective Studies , Early Detection of Cancer , Middle Aged
6.
Int. braz. j. urol ; 45(4): 671-678, July-Aug. 2019. tab, graf
Article in English | LILACS | ID: biblio-1019884

ABSTRACT

ABSTRACT Introduction Penile cancer (PC) occurs less frequently in Europe and in the United States than in South America and parts of Africa. Lymph node (LN) involvement is the most important prognostic factor, and inguinal LN (ILN) dissection can be curative; however, ILN dissection has high morbidity. A nomogram was previously developed based on clinicopathological features of PC to predict ILN metastases. Our objective was to conduct an external validation of the previously developed nomogram based on our population. Materials and methods We included men with cN0 ILNs who underwent ILN dissection for penile carcinoma between 2000 and 2014. We performed external validation of the nomogram considering three different external validation methods: k-fold, leave-one-out, and bootstrap. We also analyzed prognostic variables. Performance was quantified in terms of calibration and discrimination (receiver operator characteristic curve). A logistic regression model for positive ILNs was developed based on clinicopathological features of PC. Results We analyzed 65 men who underwent ILN dissection (cN0). The mean age was 56.8 years. Of 65 men, 24 (36.9%) presented with positive LNs. A median 21 ILNs were removed. Considering the three different methods used, we concluded that the previously developed nomogram was not suitable for our sample. Conclusions In our study, the previously developed nomogram that was applied to our population had low accuracy and low precision for correctly identifying patients with PC who have positive ILNs.


Subject(s)
Humans , Male , Adult , Aged , Aged, 80 and over , Penile Neoplasms/pathology , Carcinoma/pathology , Nomograms , Inguinal Canal/pathology , Lymph Nodes/pathology , Lymphatic Metastasis/diagnosis , Reference Values , Logistic Models , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Risk Factors , ROC Curve , Tumor Suppressor Protein p53/analysis , Statistics, Nonparametric , Neoplasm Grading , Lymph Node Excision , Middle Aged , Neoplasm Staging
7.
Int. braz. j. urol ; 44(1): 114-120, Jan.-Feb. 2018. tab, graf
Article in English | LILACS | ID: biblio-892954

ABSTRACT

ABSTRACT Objectives Report the long-term outcomes of the AMS 800 artificial sphincer (AS) for the treatment post-prostatectomy incontinence (PPI) in a single center in Brazil. Materials and Methods Clinical data from patients who underwent the procedure were retrieved from the medical records of individuals with more than 1 year of follow-up from May 2001 to January 2016. Continence status (number of pads that was used), complications (erosion or extrusion, urethral atrophy, and infection), malfunctions, and need for secondary implantation were evaluated. The relationship between complications and prior or subsequent radiation therapy (RT) was also examined. Results From May 2001 to January 2016, 121 consecutive patients underwent AS implantation for PPI at an oncological referral center in Brazil. At the last visit, the AS remained implanted in 106 patients (87.6%), who reported adequate continence status (maximum of 1 pad/day). Eight-two subjects (67.8%) claimed not to be using pads on a regular basis at the final visit (completely dry). Revision occurred in 24 patients (19.8%). Radiation therapy (RT) for prostate cancer following radical prostatectomy was used in 47 patients before or after AS placement. Twelve patients with a history of RT had urethral erosion compared with 3 men without RT (p=0.004). Conclusion Considering our outcomes, we conclude that AS implantation yields satisfactory results for the treatment of PPI and should remain the standard procedure for these patients. Radiation therapy is a risk factor for complication.


Subject(s)
Humans , Male , Postoperative Complications/therapy , Prostatectomy/adverse effects , Urinary Incontinence/therapy , Urinary Sphincter, Artificial , Prosthesis Implantation/methods , Postoperative Complications/etiology , Radiotherapy Dosage , Urethra/surgery , Urinary Incontinence/etiology , Urodynamics , Brazil , Retrospective Studies , Risk Factors
8.
Rev. SOBECC ; 22(3): 152-160, jul.-set. 2017.
Article in English, Portuguese | LILACS, BDENF | ID: biblio-859107

ABSTRACT

Objetivos: Verificar a efetividade do Protocolo Prevenção de Lesão de Pele, por meio do levantamento de ocorrências causadas pelo posicionamento cirúrgico em pacientes oncológicos submetidos às cirurgias urológicas robóticas e demonstrar a importância da simulação como estratégia educativa no treinamento da equipe de enfermagem. Método: Trata-se de uma pesquisa descritiva, retrospectiva, abordagem quantitativa, referente ao ano de 2015. O estudo foi feito no centro cirúrgico de um hospital oncológico que realiza em média 1.000 cirurgias/mês. Resultados: Em 2015, foram realizados 359 procedimentos urológicos robóticos, sendo 298 casos de prostatectomia. Não houve nenhuma lesão de pele por posicionamento no período observado. Conclusão: A ocorrência de lesões de pele em pacientes oncológicos submetidos a cirurgias urológicas robóticas, associada ao posicionamento cirúrgico, neste estudo, foi zero. Esse resultado comprova a efetividade do protocolo institucional demonstrando a importância da simulação como estratégia educativa de melhoria para garantir o sucesso do posicionamento cirúrgico robótico.


Objectives: To verify the effectiveness of the Skin Lesion Prevention Protocol by analyzing the occurrence of lesions caused by surgical positioning in cancer patients undergoing robotic urological surgeries; to demonstrate the importance of simulations as educational strategies for training nursing teams. Method: This study includes a descriptive, retrospective, quantitative approach, and refers to the year of 2015. The study was performed at the surgery center of a cancer hospital that performs on average 1,000 surgeries per month. Results: In 2015, 359 robotic urological procedures were performed, of which 298 cases were prostatectomies. There were no skin lesions caused by positioning in the observed period. Conclusion: In this study, the occurrence of skin lesions associated with the surgical positioning of cancer patients undergoing robotic urological surgeries was zero. This result proves the effectiveness of the institutional protocol and demonstrates the importance of simulation as an educational improvement strategy to guarantee the success of robotic surgical positioning.


Objetivos: Verificar la efectividad del Protocolo Prevención de Lesión de Piel, por medio del levantamiento de ocurrencias causadas por el posicionamiento quirúrgico en pacientes oncológicos sometidos a las cirugías urológicas robóticas e demostrar la importancia de la simulación como estrategia educativa en la capacitación del equipo de enfermería. Método: Se trata de un estudio descriptivo, retrospectivo, abordaje cuantitativo, referente al año 2015. El estudio fue hecho en el centro quirúrgico de un hospital oncológico que realiza en promedio 1.000 cirugías/mes. Resultados: En 2015, fueron realizados 359 procedimientos urológicos robóticos, siendo 298 casos de prostatectomía. No hubo ninguna lesión de piel por posicionamiento en el período observado. Conclusión: La ocurrencia de lesiones de piel en pacientes oncológicos sometidos a cirugías urológicas robóticas, asociada al posicionamiento quirúrgico, en este estudio, fue cero. Ese resultado comprueba la efectividad del protocolo institucional demostrando la importancia de la simulación como estrategia educativa de mejoría para garantizar el éxito del posicionamiento quirúrgico robótico.


Subject(s)
Humans , Male , Adult , Middle Aged , Aged , Aged, 80 and over , Prostatectomy , Urologic Neoplasms , Video-Assisted Surgery , General Surgery , Education, Nursing , Simulation Training
9.
Int. braz. j. urol ; 43(1): 29-35, Jan.-Feb. 2017. tab, graf
Article in English | LILACS | ID: biblio-840796

ABSTRACT

ABSTRACT Objectives To evaluate the predictive value of TRIMprob test to detect prostate cancer (PCa) in patients referred to prostate biopsy (PB). Material and Methods Patients with PSA <10ng/mL and rectal exam without findings suggestive of prostate cancer were selected for TRIMprob evaluation. Exam was performed by a single operator through transperineal approach. Patients admitted for the study were submitted to TRIMprob and multiparametric magnetic resonance (mpMRI) and posteriorly to PB. Results In total, 77 patients were included. TRIMprob showed evidences of PCa in 25 (32.5%) and was negative in 52 patients (67.5%). The rate of detection of prostate cancer at biopsy was higher in patients with positive TRIMprob (16/25; 64.0%) than in patients with negative TRIMprob (11/52; 21.1%; p<0.001). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of TRIMprob were respectively 61.5%, 82.0%, 64.0%, 80.3% and 74.0%. ROC curve showed the following areas under the curve values for TRIMprob, mpMRI and combination of TRIMprob + mpMRI: 0.706; 0.662 and 0.741 respectively. At combined analysis, when both TRIMprob and mpMRI were negative for prostate cancer, accuracy was 96.3% or only 1 in 27 PB was positive (3.7%). Conclusions Trimprob had similar predictive value for PCa in patients submitted to PB as mpMRI. Combined TRIMprob and mpMRI showed higher accuracy than when performed singly.


Subject(s)
Humans , Male , Adult , Aged , Prostatic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Diagnostic Techniques, Urological/instrumentation , Prostate/pathology , Prostate/diagnostic imaging , Prostatic Neoplasms/pathology , Reference Values , Biopsy , Cross-Sectional Studies , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity , Prostate-Specific Antigen/blood , Age Distribution , Neoplasm Grading , Middle Aged
10.
Int. braz. j. urol ; 42(6): 1136-1143, Nov.-Dec. 2016. tab, graf
Article in English | LILACS | ID: biblio-828936

ABSTRACT

ABSTRACT Introduction: The presence and extension of inguinal lymph node metastasis are the main prognostic factors in patients with penile cancer. Physical exam and image exams are not adequate to evaluate inguinal lymph nodes and many patients are submitted to non-therapeutic lymphadenectomies. However, it is known that not all patients with clinically or histologically negative inguinal lymph nodes evolve favorably. Casuistic and Methods: the authors evaluated the clinical and pathologic characteristics of 163 patients with penile carcinoma and clinically negative inguinal lymph nodes followed for three or more years and their impact on global survival (GS) and cancer-specific survival (CSS) in the 10-year follow-up. Primary pathologic tumor stage (p=0.025) and the presence of high grade of tumor differentiation (p=0.018) were predictive of CSS. The presence of high grade tumor was an independent specific prognostic factor of death risk (RR 14.08; p=0.019). Conclusion: high histologic grade was an independent predictive factor of specific death risk in patients with penile carcinoma and clinically negative lymph nodes followed for three or more years.


Subject(s)
Humans , Male , Adult , Aged , Penile Neoplasms/pathology , Carcinoma, Squamous Cell/pathology , Lymph Nodes/pathology , Penile Neoplasms/mortality , Prognosis , Brazil/epidemiology , Carcinoma, Squamous Cell/mortality , Risk Factors , Follow-Up Studies , Neoplasm Grading , Lymphatic Metastasis , Middle Aged , Neoplasm Staging
11.
São Paulo med. j ; 132(5): 297-302, 08/2014. tab, graf
Article in English | LILACS | ID: lil-721007

ABSTRACT

CONTEXT AND OBJECTIVE: Chordoma is a rare tumor with a high risk of locoregional recurrences. The aim of this study was analyze the long-term results from treating this pathological condition. DESIGN AND SETTING: Cohort study in a single hospital in São Paulo, Brazil. METHODS: This was a retrospective cohort study on 42 patients with chordoma who were treated at Hospital A. C. Camargo between 1980 and 2006. The hospital records were reviewed and a descriptive analysis was performed on the clinical-pathological variables. Survival curves were estimated using the Kaplan-Meier method and these were compared using the log-rank test. RESULTS: Nineteen patients were men and 23 were women. Twenty-five tumors (59.5%) were located in the sacrum, eleven (26.2%) in the skull base and six (14.3%) in the mobile spine. Surgery was performed on 28 patients (66.7%). The resection was considered to have negative margins in 14 cases and positive margins in 14 cases. The five-year overall survival (OS) was 45.4%. For surgical patients, the five-year OS was 64.3% (82.2% for negative margins and 51.9% for positive margins). In the inoperable group, OS was 37.7% at 24 months and 0% at five years. CONCLUSION: Complete resection is related to local control and definitively has a positive impact on long-term survival. .


CONTEXTO E OBJETIVO: Cordoma é um tumor raro e com alto risco de recidiva locorregional. O objetivo deste estudo foi analisar os resultados a longo prazo do tratamento dessa doença. TIPO DE ESTUDO E LOCAL: Estudo de coorte realizado em um único hospital em São Paulo, Brasil. MÉTODOS: Estudo de coorte retrospectivo com 42 pacientes com cordoma tratados de 1980 e 2006 no Hospital A. C. Camargo. Os prontuários foram revistos e foi realizada a análise descritiva das variáveis clínicas e patológicas. As curvas de sobrevida foram estimadas pelo método de Kaplan-Meier e a comparação entre elas, pelo teste de log-rank. RESULTADOS: Dezenove pacientes eram homens e 23, mulheres. Vinte e cinco tumores (59,5%) estavam localizados no sacro, 11 (26,2%) na base do crânio e 6 (14,3%), na coluna móvel. A cirurgia foi realizada em 28 pacientes (66,7%). A ressecção foi considerada como tendo margens negativas em 14 casos e margens comprometidas em 14 pacientes. A sobrevida global (SG) em 5 anos foi de 45,4%. Para os pacientes cirúrgicos, a SG em 5 anos foi de 64,3% (82,2% para as margens negativas e 51,9% de margens positivas). No grupo inoperável, a SG em 24 meses foi de 37,7% e 0% em 5 anos. CONCLUSÃO: A ressecção completa está relacionada com o controle local e, definitivamente, tem impacto positivo na sobrevida a longo prazo. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Young Adult , Chordoma/mortality , Sacrum , Skull Base Neoplasms/mortality , Spinal Neoplasms/mortality , Brazil/epidemiology , Chordoma/radiotherapy , Chordoma/surgery , Medical Records , Neoplasm Recurrence, Local/mortality , Retrospective Studies , Skull Base Neoplasms/radiotherapy , Skull Base Neoplasms/surgery , Spinal Neoplasms/radiotherapy , Spinal Neoplasms/surgery , Survival Rate , Treatment Outcome
12.
Rev. Col. Bras. Cir ; 40(6): 471-475, nov.-dez. 2013. ilus, graf, tab
Article in Portuguese | LILACS | ID: lil-702656

ABSTRACT

OBJETIVO: avaliar a frequência de deleção do gene PTEN no carcinoma de células renais e o impacto da deleção nas taxas de sobrevida global e livre de doença. MÉTODOS: foram analisados 110 pacientes portadores de carcinoma de células renais submetidos à nefrectomia radical ou parcial entre os anos de 1980 e 2007. Em 53 casos foi possível a análise do gene PTEN pelo método de hibridização in situ fluorescente através da técnica de "tissue microarray". Para a análise estatística, os pacientes foram classificados em dois grupos, de acordo com a presença ou ausência de deleção. RESULTADOS: o tempo médio de seguimento foi de 41,9 meses. Deleção hemizigótica foi identificada em 18 pacientes (33,9%), ao passo que deleção homozigótica esteve presente em três (5,6%). Em aproximadamente 40% dos casos analisados havia deleção. Monossomia e trissomia foram detectadas, respectivamente, em nove (17%) e dois pacientes (3,8%). Em 21 pacientes (39,6%), a análise por hibridização in situ do gene PTEN foi normal. Não houve diferenças estatisticamente significativas nas taxas de sobrevida global (p=0,468) e livre de doença (p=0,344) entre os pacientes portadores ou não de deleção. Foram fatores independentes para a sobrevida global: estádio clínico TNM, sintomatologia ao diagnóstico, alto grau de Fuhrmann performance status (Ecog) e recorrência tumoral. A livre de doença foi influenciada unicamente pelo estádio clínico TNM. CONCLUSÃO: deleção do gene PTEN no CCR foi detectada com frequência de aproximadamente 40% e sua presença não foi determinante de menores taxas de sobrevida, permanecendo os fatores prognósticos tradicionais como determinantes da evolução dos pacientes.


OBJECTIVE: To evaluate the frequency of deletion of the PTEN gene in renal cell carcinoma (RCC) and its impact on the rates of overall and disease-free survival. METHODS: We analyzed 110 patients with renal cell carcinoma who underwent radical or partial nephrectomy between 1980 and 2007. In 53 cases it was possible to analyse the PTEN gene by the method of fluorescent in situ hybridization using the technique of tissue microarray. For statistical analysis, patients were classified in two groups according to the presence or absence of the deletion. RESULTS: The mean follow-up time was 41.9 months. Hemizygous deletion was detected in 18 patients (33.9%), while the homozygous one was present in three (5.6%). Deletion was present in approximately 40% of the analyzed cases. Monosomy and trisomy were detected in nine (17%) and two patients (3.8%), respectively. In 21 patients (39.6%) the analysis of the PTEN gene by in situ hybridization was normal. There were no statistically significant differences in overall (p = 0.468) and disease-free (p = 0.344) survival rates between patients with or without deletion. Factors which were independent for overall survival: TNM clinical stage, symptoms at diagnosis, high Fuhrmann grade, performance status (ECoG) and tumor recurrence. Disease-free survival was influenced only by the clinical TNM stage. CONCLUSION: Deletion of the PTEN gene in RCC was detected with a frequency of approximately 40% and its presence was not determinant of lower survival rates, the traditional prognostic factors remaining as determinants of outcome.


Subject(s)
Female , Humans , Male , Middle Aged , Carcinoma, Renal Cell/genetics , Gene Deletion , Kidney Neoplasms/genetics , PTEN Phosphohydrolase/genetics , Carcinoma, Renal Cell/mortality , Disease-Free Survival , In Situ Hybridization, Fluorescence , Kidney Neoplasms/mortality , Retrospective Studies , Survival Rate , Tissue Array Analysis
13.
Int. braz. j. urol ; 39(2): 182-188, Mar-Apr/2013. tab, graf
Article in English | LILACS | ID: lil-676266

ABSTRACT

Purpose To evaluate preoperative rectal electrical stimulation in the recovery of urinary continence in patients who undergo radical retropubic prostatectomy. Materials and Methods Patients were divided into 3 randomized groups: control, pelvic exercises, and electrical stimulation. A 1 hour pad-test, the ICIQ-SF, and the SF-36 were performed 1, 3, and 6 months after the surgical procedure. Results Of the 58 patients who were initially included in the study, 9 were excluded due to radiotherapy after surgical intervention, an indwelling urethral catheter for more than 30 days, high surgical risk, loss of follow-up, or incomplete participation in the study routines and spontaneous interruption. Forty-nine patients concluded the study (15 in the control group, 17 in the exercise group, and 17 in the electrical stimulation group). We did not observe any significant difference in the pad test (p > 0.05), the 8 domains of the SF-36, or ICIQ-SF score compared with control groups (control, exercise, and electrical stimulation). Conclusion Preoperative rectal electrical stimulation has no impact on continence status in patients who undergo radical retropubic prostatectomy. There is no difference in the three above mentioned groups with regard to urinary leakage and quality of life. .


Subject(s)
Aged , Humans , Male , Middle Aged , Electric Stimulation Therapy/methods , Muscle, Skeletal/physiology , Prostatectomy/adverse effects , Urinary Incontinence/prevention & control , Epidemiologic Methods , Exercise Therapy/methods , Muscle Contraction/physiology , Pelvic Floor , Preoperative Period , Prostatectomy/methods , Quality of Life , Time Factors , Treatment Outcome
14.
In. Lopes, Ademar; Chammas, Roger; Iyeyasu, Hirofumi. Oncologia para a graduação. São Paulo, Lemar, 3; 2013. p.483-492. (Oncologia para a graduação).
Monography in Portuguese | LILACS | ID: lil-692035
15.
Int. braz. j. urol ; 38(4): 456-465, July-Aug. 2012. tab
Article in English | LILACS | ID: lil-649438

ABSTRACT

PURPOSE: To analyze the immunohistochemical expression of the standard isoform of CD44 (CD44s) adhesion molecule in clear cell renal cell carcinoma (CCRCC) and its impact on clinical outcomes. MATERIALS AND METHODS: Ninety-nine consecutive patients treated surgically for RCC between 1992 and 2009 were selected. A single pathologist reviewed all cases to effect a uniform reclassification and determine the most representative tumor areas for construction of a tissue microarray. The same pathologist, who was blinded to the outcome of the cases, semi-quantitatively scored the staining intensity of CD44s in all specimens. The counting was done using the H-Score algorithm. RESULTS: Of the 99 immunostained RCC specimens, 57(57.7%) showed low expression, and 42(42.4%) showed high expression levels of CD44s. The expression of CD44s was directly associated with tumor size (p = 0.03), clinical stage (p = 0.02) and Fuhrman grade (p = 0.02). Disease specific survival (DSS) rates for patients whose specimens expressed low and high levels of CD44s was 88.1% and 67.5%, respectively (p = 0.009). Progression free survival (PFS) rates in patients with low and high expression of CD44s were 78.8% and 61.7%, respectively (p = 0.05). Classical features such as the presence of metastasis and clinical stage remained isolated predictors of survival. CONCLUSIONS: Immunohistochemical expression of CD44s was associated with important clinical variables such as stage and Fuhrman grade. However, it was not an independent predictor of survival. Therefore, we believe it has a limited role as a prognostic marker in patients with CCRCC.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , /analysis , Carcinoma, Renal Cell/immunology , Biomarkers, Tumor/analysis , Carcinoma, Renal Cell/chemistry , Carcinoma, Renal Cell/pathology , Epidemiologic Methods , Immunohistochemistry , Prognosis , Sex Distribution , Time Factors , Tissue Array Analysis
16.
São Paulo med. j ; 128(1): 38-41, Jan. 2010. tab
Article in English | LILACS | ID: lil-547392

ABSTRACT

CONTEXT AND OBJECTIVE: Vulvar melanoma is a rare disease. We describe the experience of a single institution and review the literature. DESIGN AND SETTING: Retrospective study at the Department of Gynecology, Hospital do Cancer A. C. Camargo. METHODS: Eleven patients with vulvar melanoma attended between January 1987 and December 2006 were reviewed regarding clinicopathological characteristics, surgical therapy and follow-up. RESULTS: The initial symptoms were vulvar lesions, pruritus, pain and bleeding. The median age was 64.8 years. The median depth of invasion was 3.08 mm. The staging ranged from IB to IIIC (American Joint Committee on Cancer, 2002). All the patients underwent vulvectomy. Two patients did not undergo primary elective lymphadenectomy. Bilateral inguinal lymphadenectomy was performed on five patients, and one had unilateral inguinal lymphadenectomy. Sentinel lymph node investigation was performed on three patients. Five patients had locoregional recurrence. Prolonged survival was only achieved in the absence of lymph node involvement. The median follow-up was 56 months. The median disease-free survival was 15 months and the median overall survival was 29 months. CONCLUSIONS: The prognosis for patients with vulvar melanoma is generally poor, with a high tendency towards regional and distant recurrence. Depth of invasion and lymph node involvement are the most important prognostic factors. In most cases, resection of the lesion with adequate margins may replace vulvectomy. Elective inguinal femoral lymphadenectomy remains the standard lymph node staging procedure. Sentinel lymph node investigation is feasible and should be performed by a multidisciplinary team with experience of this method.


CONTEXTO E OBJETIVO: Melanoma de vulva é uma doença rara. Descrevemos a experiência de uma instituição e revisamos a literatura. TIPO DE ESTUDO E LOCAL: Estudo retrospectivo no Departamento de Ginecologia do Hospital do Câncer A. C. Camargo. MÉTODOS: De Janeiro de 1987 a Dezembro de 2006, foram revisados aspectos clínico-patológicos, tratamento cirúrgico e acompanhamento de 11 pacientes com melanoma de vulva. RESULTADOS: Lesão vulvar, prurido, dor e sangramento foram sintomas iniciais. A idade mediana foi 64,8 anos. A mediana da profundidade de invasão foi 3.08 mm. O estadiamento variou de IB a IIIC (American Joint Committee on Cancer, 2002). Todas as pacientes foram submetidas a vulvectomia. Duas pacientes não foram submetidas a linfadenectomia eletiva primária. A linfadenectomia inguinal bilateral foi realizada em cinco pacientes e uma foi submetida à linfadenectomia inguinal unilateral. A pesquisa do linfonodo sentinela foi realizada em três casos. Cinco tiveram recidiva locorregional. A sobrevida prolongada esteve relacionada com a ausência de comprometimento linfonodal. O tempo mediano de acompanhamento foi de 56 meses. A sobrevida mediana livre de doença foi de 15 meses e a sobrevida mediana global de 29 meses. CONCLUSÕES: O prognóstico das pacientes com melanoma de vulva geralmente é ruim, com tendência a recorrência regional e à distância. A profundidade de invasão e envolvimento linfonodal são os principais fatores prognósticos. Na maioria dos casos a ressecção da lesão com margens adequadas pode substituir a vulvectomia. A linfadenectomia inguino-femoral eletiva ainda é o procedimento padrão para estadiamento linfonodal. Pesquisa do linfonodo sentinela é factível e deve ser realizada por equipe multidisciplinar com experiência no método.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Middle Aged , Melanoma/surgery , Vulvar Neoplasms/surgery , Follow-Up Studies , Lymph Node Excision , Melanoma/pathology , Neoplasm Staging , Prognosis , Retrospective Studies , Sentinel Lymph Node Biopsy , Survival Rate , Vulvar Neoplasms/pathology
17.
São Paulo; s.n; 2010. 174 p. ilus, tab.
Thesis in Portuguese | LILACS, Inca | ID: lil-667418

ABSTRACT

Introdução: O tratamento para o câncer invasivo do pênis basea-se no tratamento do tumor primário, geralmente com amputação e na linfadenectomia regional, tratamentos que apresentam alto índice de morbidade. A presença de metástase linfonodal constitui o mais importante fator prognóstico identificado e sua avaliação por métodos clínicos e laboratoriais são falhos. Objetivos: O presente estudo visa identificar os fatores prognósticos do tumor primário e a importância das Proteínas da Placa Desmossômicas: Desmogleina, Plakoglobina e Desmoplakina e da Involucrina e a relação destes com as variáveis clínicas, demográficas e anatomopatológicas, bem como sua relação com sobrevida câncer específica e global. População e Métodos: Foram avaliados 288 pacientes portadores de carcinoma espinocelular do pênis submetidos a tratamento do tumor primário e a linfadenectomia radical ou aqueles pacientes com 5 anos de seguimento sem linfadenectomia. Resultados: A imunorreatividade da Involucrina se correlacionou com o Grau de diferenciação tumoral (p <0,001); a presença de infiltração peri-neural (p=0,002) e infiltração de corpos cavernosos (p=0,021) e a presença de coilocitose (p=0,006) e o tipo Histológico (p=0,043). A imunorreatividade da Desmoplakina se correlacionou com Antecedentes Venéreos (p=0,,13) e o Estadiamento Clinico T (p=0,002) e o Tipo Histológico (p=0,070). A imunorreatividade da Desmogleina não se correlacionou apenas a infiltração de corpos cavernosos (p=0,022) e não houve correlação da imunorreatividade da Plakoglobina com as variáveis clínico-demográficas ou anatomopatológicas. ...


Subject(s)
Humans , Male , Penile Neoplasms , Immunohistochemistry , Desmosomal Cadherins , Lymphatic Metastasis , Prognosis
18.
Rev. Col. Bras. Cir ; 36(6): 525-528, nov.-dez. 2009. ilus
Article in Portuguese | LILACS | ID: lil-539553

ABSTRACT

Por ser um procedimento de alta complexidade, a Hemicorporectomia associada a Colostomia úmida em alça deve ser empregada como procedimento de exceção. Por ser uma medida heróica trata-se do último recurso utilizado para tratamento de doenças pélvicas localmente avançadas e sem evidências de metástases à distância. Analisamos retrospectivamente os detalhes da técnica cirúrgica utilizada em um caso de carcinoma epidermóide desenvolvido em ulcera de pressão de região sacra e os resultados da primeira Hemicorporectomia associada a colostomia úmida em alça em um único tempo.


The Hemicorporectomy associated to Double-barreled wet colostomy is a high complex and heroic procedure and is to be used only exceptionally, when it is the last resource for treating locally advanced pelvic diseases in the absence of evidences of distant metastasis. We retrospectively analyzed the surgical technical details and the results from a hemicorporectomy with double-barreled wet colostomy in a single surgical time in a case of epidermoide carcinoma from a coetaneous pressure ulcer.


Subject(s)
Humans , Male , Young Adult , Carcinoma, Squamous Cell/surgery , Colostomy/methods , Pressure Ulcer/complications , Salvage Therapy/methods , Skin Neoplasms/surgery , Buttocks , Lumbar Vertebrae/surgery , Paraplegia/congenital , Retrospective Studies , Sacrococcygeal Region , Urinary Diversion/methods , Young Adult
19.
In. Coelho, Francisco Ricardo Gualda; Soares, Fernando Augusto; Foch, José; Fregnani, José Humberto Tavares Guerreiro; Zeferino, Luiz Carlos; Villa, Luisa Lina; Federico, Miriam Honda; Novaes, Paulo Eduardo Ribeiro dos Santos; Costa, Ronaldo Lúcio Rangel. Câncer do colo do útero. São Paulo, Tecmedd, 2008. p.621-629, ilus.
Monography in Portuguese | LILACS | ID: lil-494593
20.
In. Coelho, Francisco Ricardo Gualda; Soares, Fernando Augusto; Foch, José; Fregnani, José Humberto Tavares Guerreiro; Zeferino, Luiz Carlos; Villa, Luisa Lina; Federico, Miriam Honda; Novaes, Paulo Eduardo Ribeiro dos Santos; Costa, Ronaldo Lúcio Rangel. Câncer do colo do útero. São Paulo, Tecmedd, 2008. p.605-619, mapas, tab.
Monography in Portuguese | LILACS | ID: lil-494594
SELECTION OF CITATIONS
SEARCH DETAIL